The Medicines Company

MDCO

US5846881051

Pharmaceuticals

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+0.14%	-0.05%

2020	The Medicines Company Announces Board Changes	CI
2020	The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care	CI

The Medicines Company(NasdaqGS:MDCO) dropped from S&P Composite 1500

January 06, 2020 at 12:00 am EST

Latest news about The Medicines Company

The Medicines Company Announces Board Changes	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P TMI Index	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P 1000	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P Global BMI Index	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P Composite 1500	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P Biotechnology Select Industry Index	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from NASDAQ Biotechnology Index	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from NASDAQ Composite Index	20-01-06	CI
Novartis AG completed the acquisition of The Medicines Company.	20-01-02	CI
World share markets rally on revived trade hopes; dollar gains	19-11-25	RE
World share markets rally on revived trade hopes; dollar gains	19-11-25	RE
Transatlantic dealmaking sends European shares back to four-year peak	19-11-25	RE
Black Friday frenzy: Tiffany buys LVMH, Charles Schwab buys TD Ameritrade, Novartis buys Medicines Company…	19-11-25
Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker	19-11-25	RE
Transcript : Novartis AG, The Medicines Company - M&A Call	19-11-25
Novartis AG entered into definitive agreement to acquire The Medicines Company for $6.8 billion.	19-11-23	CI
Ionis Pharmaceuticals : Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion - WSJ	19-11-23	RE
Novartis Reportedly Holds Talks to Acquire Medicines Co	19-11-19	CI
Medicines : Novartis eyes Medicines Co to boost cardio franchise - report	19-11-19	RE
Transcript : The Medicines Company - Special Call	19-11-18
The Medicines Company Announces ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing	19-11-16	CI
The Medicines Company Announces Detailed Results from the ORION-9 and ORION-10 Pivotal Phase 3 Clinical Studies of Inclisiran	19-11-06	CI
Transcript : The Medicines Company, Q3 2019 Earnings Call, Oct 30, 2019	19-10-30

The Medicines Company is a global biopharmaceutical company. The Company is focused on the development of inclisiran, a twice-yearly therapy that allows administration during patients routine visits to their healthcare professionals and potentially contributes to improved patient adherence and sustained lower LDL-C levels. The Company is a subsidiary of Novartis AG.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
THE MEDICINES COMPANY	-0.05%	6.79B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+17.90%	44.31B
OTSUKA HOLDINGS CO., LTD.	+20.29%	22.17B
SANDOZ GROUP AG	+13.05%	14.62B
CIPLA LIMITED	+9.76%	13.12B
ZYDUS LIFESCIENCES LIMITED	+36.96%	11.58B
ONO PHARMACEUTICAL CO., LTD.	-8.60%	6.96B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+5.03%	5.03B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-6.46%	4.34B

Generic Pharmaceuticals

The Medicines Company

Equities

MDCO

US5846881051

Pharmaceuticals

The Medicines Company(NasdaqGS:MDCO) dropped from S&P Composite 1500

Latest news about The Medicines Company

Chart The Medicines Company

Company Profile

Sector Generic Pharmaceuticals